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Background: Chest imaging is essential in the assessment of respiratory disease in cystic ﬁbrosis (CF). High-resolution computed tomography
(HRCT) can detect progressive lung disease but involves signiﬁcant delivered dose of ionizing radiation. Magnetic resonance imaging (MRI) is
radiation-free but is rarely used in CF. Based on the limited information on the potential interest of chest MRI in CF pediatric patients, the aims of
our study were: 1) to evaluate and compare the reproducibility of HRCT and MRI scores; and 2) to evaluate the agreement between HRCT and
MRI scores using both Helbich and Eichinger scores.
Methods: In this prospective study, CF children who were having a HRCT for their routine assessment were proposed to perform a chest MRI the
same day. 17 patients were included (median age 12.7 years). Two radiologists scored independently HRCT (Helbich score) and MRI (Helbich
and Eichinger scores); and established a consensus score. Concordance was assessed using the Intraclass Correlation Coefﬁcient (ICC); and the
inter-observer reproducibility between methods was compared using Fisher's Z test for dependent observations.
Results: Concordance between readers was almost perfect for HRCT score (ICC = 96%) and MRI-Eichinger score (84%), and substantial for MRI-
Helbich score (68%). Correlation was strong between HRCT andMRI (r = 0.86 and 0.91 for HRCT and respectivelyMRI-Eichinger andMRI-Helbich
scores) and the concordance almost perfect and substantial (ICC = 86% and 78% for HRCT and respectivelyMRI-Eichinger andMRI-Helbich scores).
Conclusions: We showed that, in CF children, MRI could adequately visualize lung morphologic changes when compared with the “gold-
standard” HRCT. Regarding the potential cancer risks from associated ionizing radiation with HRCT, these results lead us to propose larger
intervals of time between two lung HRCTs with realization of lung MRI in the meantime.
© 2013 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Cystic ﬁbrosis; Children; Lung HRCT; Lung MRI1. Introduction
Cystic fibrosis (CF) is the most common severe autosomal
recessive genetic disease in Caucasians caused by mutations in⁎ Corresponding author at: Hôpital Trousseau, Pediatric Pulmonary Department,
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1569-1993/$ -see front matter © 2013 European Cystic Fibrosis Society. Published
http://dx.doi.org/10.1016/j.jcf.2013.09.003the gene encoding the cystic fibrosis transmembrane conductance
regulator (CFTR), a chloride channel expressed in epithelial cells
throughout the body. The disease affects many organs but most
critically the lungs; and CF lung disease still remains the major
cause ofmorbidity andmortality. Thanks to earlier diagnosis, better
nutritional support and mucus drainage, and better diagnosis and
treatment of CF-related complications, significant improvement
in the survival and clinical status of CF patients has been achieved
in the last decade [1]. Efficiently monitoring respiratory disease
progression is thus of great importance to adapt proper care.by Elsevier B.V. All rights reserved.
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respiratory disease of children and adults with CF. The European
consensus recommends a systematic annual chest X-ray, that
should be reiterated within one year only when there is a strong
clinical suspicion of new developments of the respiratory disease
[2]. High-resolution computed tomography (HRCT) is more
sensitive than chest X-rays, especially to detect early and
progressive lung disease [3]. However, it is unclear at what age
HRCT should be started, and how often it should be done with no
current recommendations. HRCT involves indeed a significant
delivered dose of ionizing radiation and its routine use has
therefore been questioned in the context of improved long term
survival [4,5].
In this context, proton magnetic resonance imaging (MRI),
a radiation free imaging, has emerged as an interesting tool to
image the lung [6–8]. A radiation-free alternative would
indeed be particularly attractive especially in children with a
chronic lung disease as CF [9–12]. For several years, a team in
Germany (Heidelberg) has been evaluating lung MRI and
HRCT in children and adults with CF [13–16]. Using a score
currently applied to evaluate lung HRCT, the Helbich
(modified Bhalla) score [17,18], the authors reported that
lung MRI was indeed an interesting alternative to HRCT. They
observed that MRI was comparable to HRCT for the detection
of morphologic changes in the CF lungs, allowing the visualiza-
tion of bronchiectasis, bronchial wall thickening, mucus plugging,
air fluid levels, consolidation and destruction [15,19]. However,
they also observed that the Helbich score was not easily adaptable
to MRI, leading Eichinger et al. few years later to develop a
specific lung-MRI score [14]. To our knowledge, no comparison of
the MRI-Helbich and MRI-Eichinger scores has been investigated
so far. Recently, another team in The Netherlands also showed that
chest-MRI was a promising radiation-free imaging tool to assess
structural lung abnormalities in CF patients [20].
Based on the limited information on the potential interest
of chest MRI in CF pediatric patients, and on the agreement
of different scoring systems, the aims of our study were:
1) to evaluate and compare the reproducibility of HRCT
and MRI scores; and 2) to evaluate the agreement between
HRCT and MRI scores using both Helbich and Eichinger
scores.
2. Materials and methods
2.1. Patients
This prospective study took place in the pediatric CF Center
of Trousseau Hospital from January 2011 to July 2012. In our
center, and besides clinical suspicion of new developments of
the respiratory disease, CF children have an annual chest X-ray
and a HRCT every 3 years. For this study, we proposed to the
patients who were having a HRCT between January 2011 and
July 2012 for their routine assessment to perform a chest MRI
the same day. Only patients regularly followed in our CF
Center and older than 8 years old were included. Patients and
parents were informed of the nature and goal of the investigations
performed and gave their informed consent. The study wasapproved by the hospital ethics committee. No sedation was used
for either HRCT or MRI.
2.2. HRCT examinations
Chest helical HRCT were performed using a Mx8000 IDT
32 16-slice multidetector CT (Philips, Best, The Netherlands)
with scan acquisition at 90 kV, 90 mA s, 1-mm collimation,
inspiration breath hold and 1-mm reconstruction with a high
special frequency algorithm.
2.3. MRI examinations
Chest MRI was performed using a 1.5-TMR scanner (Achieva,
Philips Healthcare, Best, The Netherlands) using a four-element
phased-array surface coil (SENSE body, Philips Healthcare, Best,
The Netherlands) in the head-first position. Images were acquired
after contrast media injection [0.1 mmol/kg, Gadoteric acid
(Dotarem, Guerbet)]. To reduce imaging time, pre-contrast
images were not acquired.
All the sequences below were acquired for each patient
and used altogether for scoring, with the following order and
parameters:
– Ultra-fast gradient echo sequence – T1-weighted high resolu-
tion isotropic volume examination (THRIVE) – repetition time
(TR)/echo time (TE)/flip angle (FA) 4 ms/2 ms/10°, slice
thickness 2 mm, patient-adapted field of view (FOV), transver-
sal orientation, end-inspiratory breath hold, total imaging time
approximately 15 s, number of slices 113;
– T1-weighted turbo spin-echo sequence — TR/TE/FA
629 ms/11 ms/90°, slice thickness 4 mm, patient-adapted
FOV, transversal orientation, total imaging time approxi-
mately 5 min and 27 s, number of slices 40;
– T1-weighted fast field echo (FFE) — TR/TE/FA 105 ms/2.3
(in-phase) and 4.7 (out-of-phase) ms/80°, slice thickness 5 mm,
patient-adapted FOV, coronal orientation, end-inspiratory
breath hold, total imaging time approximately 33 s, number of
slices 25;
– T2-weighted turbo spin-echo sequence — TR/TE/FA
5552 ms/30 ms/90°, slice thickness 4 mm, patient-adapted
FOV, transversal orientation, respiratory-gated acquisition,
total imaging time approximately 27 s, number of slices 25;
– T2-weighted turbo spin-echo sequence — TR/TE/FA
2000 ms/30 ms/90°, slice thickness 4 mm, patient-adapted
FOV, coronal orientation, respiratory-gated acquisition, total
imaging time approximately 50 s, number of slices 25.
2.4. Image analyses
Image analyses were done by 2 independent readers with
20 years (reader 1 (R1, HDLP)) and 4 years (reader 2 (R2, CS)) of
experience in pediatric respiratory radiology. They firstly scored
independently chest HRCT and chest MRI; and secondly
established a consensus score for each parameter. For HRCT,
they applied the scoring system developed by Helbich et al.,
maximum 27 [18]. For MRI, two scores were used: 1) the score
Table 1






HRCT (Helbich) 27 1–18 96%
Severity of bronchiectasis 3 0–3 92%
Severity of peribronchial wall thickening 3 0–3 53%
Extent of bronchiectasis 3 0–3 79%
Extent of mucous plugging 3 0–3 94%
Extent of sacculations or abscesses 3 0–2 88%
Generations of bronchial divisions involved 3 0–3 93%
Severity of bullae 3 0–1 100%
Severity of emphysema 2 0–0 100%
Severity of mosaic perfusion 2 0–2 84%
Severity of collapse or consolidation 2 0–1 100%
MRI (Helbich) 27 2–17 68%
Severity of bronchiectasis 3 0–3 75%
Severity of peribronchial wall thickening 3 0–3 56%
Extent of bronchiectasis 3 0–3 60%
Extent of mucous plugging 3 0–3 66%
Extent of sacculations or abscesses 3 0–1 0%
Generations of bronchial divisions involved 3 0–3 45%
Severity of bullae 3 0–0 100%
Severity of emphysema 2 0–0 100%
Severity of mosaic perfusion 2 0–2 65%
Severity of collapse or consolidation 2 0–1 100%
MRI (Eichinger) 60 0–24 84%
Bronchiectasis/wall thickening 12 0–12 73%
Mucus plugging 12 0–12 88%
Abscesses/sacculations 12 0–0 100%
Consolidation 12 0–2 40%
Special findings 12 0–0 100%
Abbreviations: HRCT: high-resolution computed tomography; MRI: magnetic
resonance imaging.
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developed by Eichinger et al. for semi-quantitative evaluation of
CF lung disease using MRI [14]. As the functional parameter
of the score, evaluating the functional impairment, was not
considered for this study, the maximum possible score was 60
[16]. For MRI, the sequences altogether were used to score. Each
reader was blinded to the patients' clinical and functional data and
to the other reader's and score's findings. Within one-month
interval, the radiologists read firstly MRI using Eichinger score,
then MRI using Helbich score, and finally HRCT using Helbich
score.
2.5. Statistical methods
Quantitative variables were expressed as median and range.
Pearson's correlation coefficient was used to correlate scores.
The concordance was assessed using the Intraclass Correlation
Coefficient (ICC) computed as the ratio of between patients
variance to overall variance. Bland and Altman plots were
used to summarize the concordance among methods; limits of
agreement were computed for comparing methods [21]. The
Landis & Koch interpretation scale was used to qualify the
strength of concordance: ICC b 0 “none”, 0.0 b ICC b 0.2
“slight”, 0.2 b ICC b 0.4 “fair”, 0.4 b ICC b 0.6 “moderate”,
0.6 b ICC b 0.8 “substantial” and ICC N 0.8 “almost perfect”
[22]. Inter-observer reproducibility between methods was
compared using Fisher's Z test for dependent observations
[23]. Concordance levels of HRCT with the 2 MRI approaches
were compared with a permutation test: 1000 permuted
samples were obtained by randomly permuting the 2 MRI
measurements in each individual. The p-value was com-
puted as the percentage of permuted ICC differences more
extreme than the observed ICC difference. The threshold




17 CF children were prospectively included: 9 females, 8
males; median age 12.7 years [range: 9.1–20.2 years]. Among
the 17 patients, 15 were pancreatic insufficient and none had
CF-related liver disease or diabetes. Median FEV1 was 84%
[range: 48–118%] and FVC 85% [range: 74–112%].
3.2. Concordance between the readers
Concordance between the scores of the two readers was
calculated for HRCT and for MRI with the two scoring systems
(Table 1). Median HRCT score for R1 was 10 [range: 1–18], and
11 for R2 [range: 1–18]; the median consensus score was 11
[range: 1–18]. Overall, the concordance between readers was
“almost perfect” for HRCT scores (ICC: 96%). It was also “almost
perfect” (ICC N 80%) for all components, except for “extent
of bronchiectasis” (ICC = 79%, “substantial” concordance)and “severity of peribronchial wall thickening” (ICC = 52%,
“moderate” concordance).
Median MRI-Helbich score for R1 was 9 [range: 2–17], and
12 for R2 [range: 7–17]. Overall, the concordance was
“substantial” (ICC = 68%). For the sub-items, the concordance
ranged from “substantial” (ICC = 75% for “severity of bronchi-
ectasis”) to “slight” (ICC = 0% for “extent of sacculations or
abscesses”, parameter however scored only 1, and in 1 patient). It
was “almost perfect” (ICC = 100%) for 2 items (“severity of
bullae” and “severity of emphysema”), however, those two items
were never reported.
Median MRI-Eichinger score for R1 was 13 [range: 2–24],
and 9 for R2 [range: 0–19]. Overall, the concordance between
readers was “almost perfect” with this score (ICC = 84%).
Similarly to the MRI-Helbich score, the concordance was perfect
for the sub-item “abscesses/sacculations” (ICC = 100%), but
none was reported. Otherwise, the concordance was “almost
perfect” for “mucus plugging” (ICC = 88%), and “substantial”
for “bronchiectasis/wall thickening” (ICC = 73%); but “moder-
ate” for “consolidation” (ICC = 40%).
Overall, the concordance between readers was larger for
HRCT than that for either MRI scores (Eichinger p = 0.013;
Helbich p = 0.0002); the difference between the 2 MRI scores
being less marked (p = 0.19).
Table 2








Total score 27 1–18 6–16 78%
Severity of bronchiectasis 3 0–3 1–3 79%
Severity of peribronchial
wall thickening
3 1–2 1–2 47%
Extent of bronchiectasis 3 0–3 1–3 76%
Extent of mucous plugging 3 0–3 0–3 75%
Extent of sacculations or abscesses 3 0–1 0–1 47%
Generations of bronchial
divisions involved
3 0–3 2–3 36%
Severity of bullae 3 0–1 0–0 0%
Severity of emphysema 2 0–0 0–0 100%
Severity of mosaic perfusion 2 0–2 0–2 60%
Severity of collapse or
consolidation
2 0–1 0–1 56%
Abbreviations: HRCT: high-resolution computed tomography; MRI: magnetic
resonance imaging.
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A consensus measurement was obtained for each patient and
with each score. The number of changes between the initial and
the consensus score was similar for each reader (30 changes/58
readings), as was the magnitude of score changes (1.9 vs. 2.0
points on average).
The median consensus score was 11 [range: 1–18] for
HRCT, 11 [range: 0–20] for MRI-Eichinger, and 12 [range: 6–
16] for MRI-Helbich. The correlation was strong between
HRCT and MRI-Eichinger scores (r = 0.86, p b 0.0001), the
concordance “almost perfect” (ICC = 86%), with 2 measure-
ments in the same person less than 7 points away (limits of
agreement [−6.6, 6.6] CI95%). HRCT and MRI-Helbich scores
were strongly correlated (r = 0.91, p b 0.0001), and exhibited
“substantial” concordance (ICC = 78%), with 2 measurements
in the same person less than 7 points away (limits of agreement
[−6.7, 6.7] CI95%). The concordance of each MRI score with
HRCT was similar (0.86 vs. 0.78, permutation test, p = 0.295).
We observed, as illustrated in Fig. 1 (left), that although well
correlated and concordant, the score ranges with MRI were
narrower than those with HRCT. The Bland & Altman plot in
Fig. 1 (right) shows a systematic pattern, with MRI scores
always less extreme than the corresponding HRCT scores, in
low as well as in large measurements.
The concordance between the sub-items of HRCT and
MRI-Helbich scores is detailed in Table 2. Some sub-items
exhibited a “substantial” concordance, such as “severity
of bronchiectasis” (ICC = 79%), “extent of bronchiectasis”
(ICC = 76%) and “extend of mucous plugging” (ICC = 75%).
The least concordant items were “severity of peribronchial wall
thickening” (ICC = 47%), “generations of bronchial divisions
involved” (ICC = 36%) and “extent of sacculations or abscesses”
(ICC = 47%). The “severity of bullae” was also poorly
concordant, however it was only reported once in all readings
with a score of 1 out of 3.Fig. 1. Comparison of HRCT and MRI Helbich scores. (Left) HRCT (high-resolution
for each patient. The points were jittered to avoid overlap. (Right) Bland–Altman pFigs. 2 and 3 illustrate the HRCT/MRI concordance for the
detection of bronchiectasis, peribronchial wall thickening and
mucous plugging on CT and MRI. Moreover, Fig. 3 shows the
presence of a patchwork of regions of different intensities on T2
respiratory-gated lung MRI in relation with a mosaic attenuation
pattern (compared to HRCT images acquired at suspended
end-inspiratory volume).
4. Discussion
In this study, we showed that, in CF children, MRI could
adequately visualize lung morphologic changes when com-
pared with HRCT, considered as the “gold standard”. So far,
only two teams worldwide, in Germany and The Netherlands,
reported that MRI provided information comparable to HRCT
in CF [15,19,20]. We observed an overall concordance between
readers along with a good correlation between HRCT and MRI,computed tomography) and MRI (magnetic resonance imaging) Helbich scores
lot of HRCT and MRI score differences according to average score.
Fig. 2. Lung HRCT and MRI for 2 patients with cystic fibrosis. Transverse lung HRCT (high-resolution computed tomography) (a, b), T2-weighted (c) and
T1-weighted post-contrast lung MRI (magnetic resonance imaging) obtained for a 16-year-old (a, c) and for an 11-year-old (b, d) patient with cystic fibrosis.
Bronchiectasis (white arrows), peribronchial wall thickening (black arrows) and mucous plugging (stars) are well depicted.
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to evaluate CF lung disease and to detect respiratory changes.
The HRCT image scoring method had an almost perfect
inter-observer reliability (ICC for the total score: 96%). The only
exception was in the assessment of the severity of the
peribronchial wall thickening (ICC = 53%), this parameter being
known as more subjective [17]. The inter-observer reliability was
smaller for MRI measurements, although it remained “almost
perfect” with the Eichinger score (ICC = 84%) and “substantial”
with the Helbich score (ICC = 68%). Altogether, the correlation
and concordance were large between HRCT and the two MRI
scores. Importantly, a systematic pattern existed causing the
scores' range to be reduced with MRI compared to HRCT: the
scores were less extreme with MRI than with HRCT. This
difference might be explained by the reduced spatial resolution of
MRI compared to CT.
We also evaluated the HRCT/MRI concordance of the
several sub-items of the scores, this evaluation being possible
when the same scoring method was applied, i.e. with the
Helbich score. The best concordances were observed for
“severity of bronchiectasis” and “extend of bronchiectasis”, a
major CF feature. Puderbach et al. had however previously
shown that the spatial resolution of MRI was not high enough
to differentiate between bronchiectasis and wall thickening,especially in the periphery of the lung [15]. The direct
visualization of the airways with MRI is indeed limited to
airways with diameters larger than 3 mm, unless filled with
bright materials such as retained mucus. With a higher spatial
resolution, HRCT is known to better visualize small peripheral
airways than MRI [6,15,19,24]. Despite these limitations, we
observed in our pediatric CF patients that MRI was comparable
to HRCT in the detection of bronchiectasis.
The HRCT/MRI concordance was also “substantial” for
“extent of mucous plugging”, known to be well visualized with
MRI, even in the small airways (high T2 signal and no
enhancement on T1-weighted images) [19,24]. Moreover, thanks
to the T2 respiratory-gated acquisitions, we surprisingly observed
a “substantial” concordance in the detection of the “mosaic
perfusion”, better defined, according to the glossary of terms for
thoracic imaging of the Fleischner Society, as a “mosaic
attenuation pattern” [25]. Air trapping due to bronchial or
bronchiolar obstruction may produce focal zones of decreased
attenuation, an appearance that can be enhanced by using
expiratory images on CT images [25]. Air trapping is indeed
known to be barely visible on morphological MRI images, as
healthy lung parenchyma already exhibits a very low signal [15].
Failo et al. had previously shown patches of parenchyma with
reduced signal intensity in end-expiratory MRI scans [20].
Fig. 3. Lung HRCT and MRI for 2 patients with cystic fibrosis. Transverse end-inspiratory breath hold lung HRCT (high-resolution computed tomography) (a, b) and
T2 respiratory-gated lung MRI (magnetic resonance imaging) (c, d) obtained for a 19-year-old (a, c) and for an 8-year-old (b, d) patient with cystic fibrosis. The
presence of a patchwork of regions of different densities and intensities in relation with a mosaic attenuation pattern is shown (asterisks). Bronchiectasis with mucous
plugging (stars) is well depicted.
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Helbich score between MRI and HRCT, we noticed that the
parameters “emphysema” and “bullae” were not appropriate,
as previously shown by the German team. Indeed, in our
pediatric population no patient had emphysema, and only one
had bullae detected on HRCT. It is recognized that these
parameters cannot be adequately assessed by MRI, as the
decrease in proton density does not lead to a substantial and
visible decrease of lung signal [14,15]. Moreover, this could
also be a “population” effect, as these features are more
frequent in adults than in children. Similar observations led the
German team to remove these parameters from the Eichinger
score [18].
We also scored the MRI using the score from Eichinger et al.,
and observed that the highest score was only 18% of the
maximum. Indeed, among this score's sub-items, “abscesses/
sacculations”, “consolidation” and “special findings” were very
rarely rated by the readers. As these parameters were uncom-
monly documented, the results may be explained by the small
size of our study population, and not by MRI technical
limitations. Although we observed no difference for the two
MRI scoring systems in terms of reproducibility and relationship
with HRCT, the two readers were subjectively found to be more
confident with the MRI-Eichinger score. Nonetheless, this score
took less time, with fewer items to quote, compared to theMRI-Helbich score. As such, we would suggest the use of the
MRI scoring system proposed by Eichinger et al.
We showed that slight lung morphological changes were
more difficult to identify in MRI readings, leading to less
extreme scores than with HRCT. These results were most likely
explained by the reduced spatial resolution of MRI compared to
CT. This raises two issues: first, it highlights the need for a
specific training for lung MRI analysis that was also evidenced
by the reduced inter-observer concordance; second, it questions
the clinical interest of visualizing mild abnormalities in the
follow-up of CF patients, as best practice guidelines are not
dependent on them [2]. Given the present limitations in MRI
due to structural limitations (reduced spatial resolution), need
for a specific training, availability and cost, it is likely that
HRCT will remain the “gold-standard” for lung imaging in CF.
However, our results show that, when available and accepted
by physicians, MRI can be considered as an alternative to
HRCT. Reducing the frequency of HRCT in children with CF
is desirable, especially in children who are more radiosensitive
than adults [26]. A recent large retrospective study has indeed
shown that radiation exposure from CT scans in childhood was
associated with subsequent risk of leukemia and brain tumors
[27]. Moreover, a recent linkage study of 11 million Australian
patients aged 0–19 years has shown that the increased
incidence of cancer after CT scan exposure was mostly due to
204 C. Sileo et al. / Journal of Cystic Fibrosis 13 (2014) 198–204irradiation [28]. This has to be paralleled with the increasing life
expectancy in CF [4,5]. As introduced, there are no international
recommendations regarding the age at which HRCT should be
started and how often it should be performed. Thus, it could be
proposed for the follow-up of children with CF to allow larger
intervals of time between 2 HRCT, and to include lung MRI
imaging in the meantime using the scoring system proposed by
Eichinger et al. Large multicentric studies will be needed in the
future to confirm lung-MRI reliability in a wide range of CF lung
disease and to include its practice into CF clinical care.
Conﬂict of interest
None of the authors have any commercial or other associations
that might pose a conflict of interest.
Acknowledgments
The authors would like to acknowledge the patients and their
families for their participation. We would also like to thank the
medical doctors and the nurses from Trousseau CF Center for
their help in recruiting the patients: Pr Brigitte Fauroux, Dr Aline
Tamalet, Mme Cécile Ledys and Mme Maryse Belson.
References
[1] Cohen-Cymberknoh M, Shoseyov D, Kerem E. Managing cystic fibrosis:
strategies that increase life expectancy and improve quality of life. Am J
Respir Crit Care Med Jun 1 2011;183(11):1463–71.
[2] Kerem E, Conway S, Elborn S, Heijerman H. Standards of care for
patients with cystic fibrosis: a European consensus. J Cyst Fibros Mar
2005;4(1):7–26.
[3] Sly PD, Brennan S, Gangell C, de Klerk N, Murray C, Mott L, et al. Lung
disease at diagnosis in infants with cystic fibrosis detected by newborn
screening. Am J Respir Crit Care Med Jul 15 2009;180(2):146–52.
[4] de Gonzalez AB, Kim KP, Samet JM. Radiation-induced cancer risk from
annual computed tomography for patients with cystic fibrosis. Am J
Respir Crit Care Med Nov 15 2007;176(10):970–3.
[5] Donadieu J, Roudier C, Saguintaah M, Maccia C, Chiron R. Estimation of
the radiation dose from thoracic CT scans in a cystic fibrosis population.
Chest Oct 2007;132(4):1233–8.
[6] Biederer J, Beer M, Hirsch W, Wild J, Fabel M, Puderbach M, et al. MRI
of the lung (2/3). Why … when … how? Insights. Insights Imaging Aug
2012;3(4):355–71.
[7] Biederer J, Mirsadraee S, Beer M, Molinari F, Hintze C, Bauman G, et al.
MRI of the lung (3/3) — current applications and future perspectives.
Insights Imaging Aug 2012;3(4):373–86.
[8] Wild JM, Marshall H, Bock M, Schad LR, Jakob PM, Puderbach M, et al.
MRI of the lung (1/3): methods. Insights Imaging Aug 2012;3(4):345–53.
[9] Fiel SB, Friedman AC, Caroline DF, Radecki PD, Faerber E, Grumbach
K. Magnetic resonance imaging in young adults with cystic fibrosis. Chest
Feb 1987;91(2):181–4.[10] Hebestreit A, Schultz G, Trusen A, Hebestreit H. Follow-up of acute
pulmonary complications in cystic fibrosis by magnetic resonance
imaging: a pilot study. Acta Paediatr Mar 2004;93(3):414–6.
[11] Hochhegger B, Irion KL, Marchiori E. Chest MRI in patients with cystic
fibrosis: a radiation-free method. Thorax Jan 2012;68(1):105–6.
[12] Kinsella D, Hamilton A, Goddard P, Duncan A, Carswell F. The role
of magnetic resonance imaging in cystic fibrosis. Clin Radiol Jul
1991;44(1):23–6.
[13] Eichinger M, Heussel CP, Kauczor HU, Tiddens H, Puderbach M.
Computed tomography and magnetic resonance imaging in cystic fibrosis
lung disease. J Magn Reson Imaging Dec 2010;32(6):1370–8.
[14] Eichinger M, Optazaite DE, Kopp-Schneider A, Hintze C, Biederer J,
Niemann A, et al. Morphologic and functional scoring of cystic fibrosis
lung disease using MRI. Eur J Radiol Jun 2012;81(6):1321–9.
[15] Puderbach M, Eichinger M, Haeselbarth J, Ley S, Kopp-Schneider A,
Tuengerthal S, et al. Assessment of morphological MRI for pulmonary
changes in cystic fibrosis (CF) patients: comparison to thin-section CT and
chest X-ray. Invest Radiol Oct 2007;42(10):715–25.
[16] Eichinger M, Puderbach M, Fink C, Gahr J, Ley S, Plathow C, et al.
Contrast-enhanced 3D MRI of lung perfusion in children with cystic
fibrosis — initial results. Eur Radiol Oct 2006;16(10):2147–52.
[17] Bhalla M, Turcios N, Aponte V, Jenkins M, Leitman BS, McCauley DI,
et al. Cystic fibrosis: scoring system with thin-section CT. Radiology Jun
1991;179(3):783–8.
[18] Helbich TH, Heinz-Peer G, Eichler I, Wunderbaldinger P, Gotz M,
Wojnarowski C, et al. Cystic fibrosis: CT assessment of lung involvement
in children and adults. Radiology Nov 1999;213(2):537–44.
[19] Puderbach M, Eichinger M, Gahr J, Ley S, Tuengerthal S, Schmahl A,
et al. Proton MRI appearance of cystic fibrosis: comparison to CT. Eur
Radiol Mar 2007;17(3):716–24.
[20] Failo R, Wielopolski PA, Tiddens HA, Hop WC, Mucelli RP, Lequin MH.
Lung morphology assessment using MRI: a robust ultra-short TR/TE 2D
steady state free precession sequence used in cystic fibrosis patients. Magn
Reson Med Feb 2009;61(2):299–306.
[21] Bland JM, Altman DG. Statistical methods for assessing agreement between
two methods of clinical measurement. Lancet Feb 8 1986;1(8476):307–10.
[22] Landis JR, Koch GG. The measurement of observer agreement for
categorical data. Biometrics Mar 1977;33(1):159–74.
[23] Donner A, Shoukri MM, Klar N, Bartfay E. Testing the equality of two
dependent kappa statistics. Stat Med Feb 15 2000;19(3):373–87.
[24] Puderbach M, Eichinger M. The role of advanced imaging techniques in
cystic fibrosis follow-up: is there a place for MRI? Pediatr Radiol Jun
2010;40(6):844–9.
[25] Hansell DM, Bankier AA, MacMahon H, McLoud TC, Muller NL, Remy
J. Fleischner Society: glossary of terms for thoracic imaging. Radiology
Mar 2008;246(3):697–722.
[26] UNSCEAR. United Nations Scientific Committee on the Effects of
Atomic Radiation. Report to the General Assembly. New York: United
Nations; 2008 . 2010.
[27] Pearce MS, Salotti JA, Little MP, McHugh K, Lee C, Kim KP, et al.
Radiation exposure from CT scans in childhood and subsequent risk of
leukaemia and brain tumours: a retrospective cohort study. Lancet Aug 4
2012;380(9840):499–505.
[28] Mathews JD, Forsythe AV, Brady Z, Butler MW, Goergen SK, Byrnes GB,
et al. Cancer risk in 680 000 people exposed to computed tomography scans
in childhood or adolescence: data linkage study of 11 million Australians.
BMJ 2013;346:f2360.
